株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

インスリンポンプ:医療機器のパイプライン評価

Insulin Pumps - Medical Devices Pipeline Assessment, 2019

発行 GlobalData 商品コード 357839
出版日 ページ情報 英文 203 Pages
即納可能
価格
本日の銀行送金レート: 1USD=109.81円で換算しております。
Back to Top
インスリンポンプ:医療機器のパイプライン評価 Insulin Pumps - Medical Devices Pipeline Assessment, 2019
出版日: 2019年07月05日 ページ情報: 英文 203 Pages
概要

当レポートでは、インスリンポンプ関連のパイプライン製品について調査しており、開発段階別の動向や製品の主要開発企業、現在継続中の治験、業界における近年の動向などの情報をお届けします。

第1章 目次

第2章 イントロダクション

  • インスリンポンプの概要

第3章 開発中の製品

  • インスリンポンプ - パイプライン製品:開発段階別
  • インスリンポンプ - パイプライン製品:セグメント別
  • インスリンポンプ - パイプライン製品:地域 (国) 別
  • インスリンポンプ - パイプライン製品:規制経路別
  • インスリンポンプ - パイプライン製品:承認時期別 (推定)
  • インスリンポンプ - 継続中の治験

第4章 インスリンポンプ - 開発中のパイプライン製品:企業別

  • インスリンポンプ企業 - パイプライン製品:開発段階別
  • インスリンポンプ - パイプライン製品:開発段階別

第5章 インスリンポンプ 開発企業と製品の概要

  • Amrita Vishwa Vidyapeetham
  • Andain, Inc
  • Cellnovo Ltd.
  • CeQur SA
  • ConvaTec Healthcare B S.a.r.l.
  • Debiotech S.A.
  • Hospira, Inc.
  • Insulet Corporation
  • InsuLine Medical Ltd.
  • LifeScan, Inc.
  • MedSolve Technologies, Inc.
  • Medtronic plc
  • MicroPort Scientific Corporation
  • NanoMed Ltd
  • Phluid Corporation
  • Sensile Medical AG
  • SFC Fluidics LLC
  • Spring Health Solutions Ltd.
  • Tandem Diabetes Care, Inc.
  • ViCentra B.V.
  • Ypsomed Holding AG

第6章 インスリンポンプ - 近年の動向

第7章 付録

図表

List of Tables

  • Table 1: Insulin Pumps - Pipeline Products by Stage of Development
  • Table 2: Insulin Pumps - Pipeline Products by Segment
  • Table 3: Insulin Pumps - Pipeline Products by Territory
  • Table 4: Insulin Pumps - Pipeline Products by Regulatory Pa

List of Figures

  • Figure 1: Insulin Pumps - Pipeline Products by Stage of Development
  • Figure 2: Insulin Pumps - Pipeline Products by Segment
  • Figure 3: Insulin Pumps - Pipeline Products by Territory
  • Figure 4: Insulin Pumps - Pipeline Products by Regulato
目次
Product Code: GDME0784EPD

GlobalData's Medical Devices sector report, "Insulin Pumps - Medical Devices Pipeline Assessment, 2019" provides an overview of Insulin Pumps currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Insulin Pumps pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Insulin Pumps under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Insulin Pumps and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Insulin Pumps under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date.

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Insulin Pumps Overview

3 Products under Development

  • 3.1 Insulin Pumps - Pipeline Products by Stage of Development
  • 3.2 Insulin Pumps - Pipeline Products by Segment
  • 3.3 Insulin Pumps - Pipeline Products by Territory
  • 3.4 Insulin Pumps - Pipeline Products by Regulatory Path
  • 3.5 Insulin Pumps - Pipeline Products by Estimated Approval Date

4 Insulin Pumps - Pipeline Products under Development by Companies

  • 4.1 Insulin Pumps Companies - Pipeline Products by Stage of Development
  • 4.2 Insulin Pumps - Pipeline Products by Stage of Development

5 Insulin Pumps Companies and Product Overview

  • 5.1 Amrita Vishwa Vidyapeetham Company Overview
  • 5.2 Andain, Inc Company Overview
  • 5.3 Becton Dickinson and Co Company Overview
  • 5.4 Cam Med LLC Company Overview
  • 5.5 Cellnovo Ltd Company Overview
  • 5.6 Debiotech SA Company Overview
  • 5.7 Hospira Inc Company Overview
  • 5.8 Insulet Corp Company Overview
  • 5.9 LifeScan Inc Company Overview
  • 5.10 MedSolve Technologies, Inc. Company Overview
  • 5.11 Medtronic plc Company Overview
  • 5.12 MicroPort Scientific Corp Company Overview
  • 5.13 Pennsylvania State University Company Overview
  • 5.14 Phluid Corporation Company Overview
  • 5.15 Sensile Medical AG Company Overview
  • 5.16 SFC Fluidics LLC Company Overview
  • 5.17 Spring Health Solutions Ltd. Company Overview
  • 5.18 Tandem Diabetes Care Inc Company Overview
  • 5.19 Terumo Corp Company Overview
  • 5.20 Thermalin Inc Company Overview
  • 5.21 Univlabs Technologies Pvt Ltd Company Overview
  • 5.22 ViCentra BV Company Overview
  • 5.23 Ypsomed Holding AG Company Overview

6 Insulin Pumps- Recent Developments

  • 6.1 Jun 11, 2019: Changes in Roche's board of directors and corporate executive committee
  • 6.2 Jun 11, 2019: Regulators demand more details on Roche's $4.8bn Spark acquisition
  • 6.3 May 28, 2019: LifeScan names Alisandra Rizzolo Head of Transformation
  • 6.4 May 23, 2019: Medtronic announces fiscal year and fourth quarter 2019 financial results
  • 6.5 May 23, 2019: Ypsomed increases EBIT and invests in long-term profitability
  • 6.6 May 20, 2019: ViCentra accelerates international expansion with appointment of new CEO
  • 6.7 May 20, 2019: LifeScan Names Ty Lee Head of Marketing
  • 6.8 May 09, 2019: Cellnovo announces the initiation of compulsory liquidation proceedings with cessation of business
  • 6.9 May 02, 2019: Insulet celebrates new global headquarters and U.S. manufacturing facility in Acton, MA
  • 6.10 May 02, 2019: Integer Holdings reports first quarter 2019 results
  • 6.11 May 02, 2019: Insulet Reports First Quarter 2019 Revenue of $159.6 Million, an Increase of 29% Year-Over-Year

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer
Back to Top